Context Therapeutics® to Participate in Two January 2022 Investor Conferences

January 4, 2022 News 0

PHILADELPHIA, Jan. 04, 2022 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological